The hospital chain’s shares traded between $2.09 and $2.35 on July 17 after closing July 16 at $2.33 per share. CHS’ share price was down 2.9 percent on July 16.
CHS has been selling off hospitals in recent years to improve its financial position and reduce its heavy debt load. In late 2017, the company announced a plan to sell a group of hospitals with combined annual revenue of $2 billion. During an earnings call on April 30, CHS Chairman and CEO Wayne Smith said the company expects to complete the hospital divestiture plan in 2019.
More articles on healthcare finance:
Medical Properties Trust invests $1.75B in 24 hospitals
Bernie Sanders pitches $20B hospital bailout plan
California hospital seeks lucrative title change
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
